Home/ Stocks/ IMCR

Immunocore Holdings plc American Depositary Shares

IMCR XNAS

$34.00 -0.50 (-1.45%) ▼ 15-min delayed

Open

$34.50

High

$34.64

Low

$33.22

Volume

492.1K

Market Cap

$1.75B

About Immunocore Holdings plc American Depositary Shares

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 524 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$106.68M	$12.97M	$0.26
FY 2025	$400.02M	$-35,514,000	$-0.71
Q3 2025	$103.69M	$-177,000	$0.00
Q2 2025	$97.96M	$-10,300,000	$-0.20

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for IMCR yet. Check out our latest market news or earnings calendar.

Get IMCR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Immunocore Holdings plc American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.